Medication class
Diabetes
Drugs for managing type 1 and type 2 diabetes, including insulin, metformin, and newer agents like GLP-1 agonists and SGLT2 inhibitors.
Data updated 2026-05-15
- 43
- Medications
- 24
- With a generic
- 58%
- Avg generic savings
- 1
- In active shortage
Drug class assignments follow the FDA openFDA therapeutic classification, and clinical details are drawn from FDA Structured Product Labeling (DailyMed). See the full sources below.
PlainMeds tracks 43 diabetes medications compiled from official FDA drug labels, including metformin, insulin glargine, insulin lispro.
Diabetes medications are grouped here by the openFDA therapeutic classification and drawn from FDA Structured Product Labeling. PlainMeds lists 43 in this class, 24 with a lower-cost generic available (averaging about 58% versus brand). Each drug page covers labeled uses, FAERS-reported side effects, interactions, recalls and NADAC pricing. This is educational information from public data, not medical advice.
What diabetes drugs cost
Highest NADAC acquisition cost per unit in this class, brand and generic
- tirzepatide
tirzepatide
$516 per unit
- dulaglutide
dulaglutide
$472 per unit
- exenatide
exenatide
$340 per unit
- semaglutide
semaglutide
$312 per unit
- glucagon
glucagon
$277 per unit
- liraglutide $87
liraglutide
$87 per unit
- insulin aspart $36
insulin aspart
$36 per unit
- insulin degludec $33
insulin degludec
$33 per unit
- insulin glargine $21
insulin glargine
$21 per unit
- empagliflozin/linagliptin $20
empagliflozin/linagliptin
$20 per unit
What this shows tirzepatide is the costliest in this class at $516.00/unit; generics in the same class run a fraction of that.
Generic availability vs other classes
56% of diabetes medications have a generic available, ranking #20 of 22 therapeutic classes (the typical class sits near 74%).
Source: CMS NADAC generic-availability flags across all PlainMeds therapeutic classes. The dot is this class; the line is the cross-class median.
acarbose
Precose
Acarbose is a medicine that helps lower blood sugar levels in people with type 2 diabetes.
View details →
alogliptin
Nesina
View details →
bromocriptine
Cycloset
Bromocriptine (Cycloset) is a medicine that acts like dopamine in your body.
View details →
canagliflozin
Invokana
Invokana is a medicine used with diet and exercise to lower blood sugar in adults with type 2 diabetes.
View details →
colesevelam
Welchol
Colesevelam is a medicine that helps lower bad cholesterol (LDL-C) and control blood sugar in adults.
View details →
dapagliflozin
Farxiga
Dapagliflozin (Farxiga) helps lower blood sugar in adults with type 2 diabetes.
View details →
diazoxide
Proglycem
VYKAT XR is a medicine used to treat excessive hunger in people with Prader-Willi syndrome.
View details →
dulaglutide
Trulicity
Trulicity is a medicine to help control blood sugar in people with type 2 diabetes.
View details →
empagliflozin
Jardiance
View details →
empagliflozin/linagliptin
Glyxambi
Glyxambi is a drug that combines three medicines to help lower blood sugar in adults with type 2 diabetes.
View details →
ertugliflozin
Steglatro
View details →
exenatide
Byetta, Bydureon
Byetta is a medicine that helps adults with type 2 diabetes control their blood sugar.
View details →
glimepiride
Amaryl
Glimepiride is a medicine that helps lower blood sugar in adults with type 2 diabetes.
View details →
glipizide
Glucotrol
Glipizide is a medicine that helps lower blood sugar in adults with type 2 diabetes.
View details →
glucagon
Baqsimi, GlucaGen
Glucagon is a medicine that helps raise your blood sugar if it gets too low.
View details →
glyburide
DiaBeta, Glynase
Glyburide is a medicine that helps lower blood sugar in adults with type 2 diabetes.
View details →
insulin NPH
Humulin N, Novolin N
Humulin N is an intermediate-acting insulin that helps control blood sugar.
View details →
insulin aspart
NovoLog, Fiasp
NovoLog (insulin aspart) is a rapid-acting insulin that helps control blood sugar in people with diabetes.
View details →
insulin degludec
Tresiba
View details →
insulin detemir
Levemir
Levemir is a long-acting insulin that helps control blood sugar levels in people with diabetes.
View details →
insulin glargine
Lantus, Basaglar, Toujeo
Basaglar is a long-acting insulin that helps control blood sugar levels.
View details →
insulin glulisine
Apidra
Apidra is a rapid-acting insulin that helps control blood sugar levels in people with diabetes.
View details →
insulin human/insulin isophane
Humulin 70/30
Humulin 70/30 is a mix of two types of insulin.
View details →
insulin lispro
Humalog
Admelog is a rapid-acting insulin that helps control blood sugar levels.
View details →
insulin regular
Humulin R, Novolin R
Humulin R is a short-acting insulin that helps control blood sugar levels in people with diabetes.
View details →
linagliptin
Tradjenta
View details →
liraglutide
Victoza, Saxenda
Liraglutide is a medicine that helps lower blood sugar levels.
View details →
metformin
Glucophage, Fortamet, Glumetza
View details →
metformin/empagliflozin
Synjardy
Synjardy is a drug that combines empagliflozin and metformin.
View details →
metformin/glipizide
Metaglip
View details →
metformin/pioglitazone
Actoplus Met
Actoplus Met is a drug that combines two medicines to help control blood sugar in adults with type 2 diabetes.
View details →
metformin/sitagliptin
Janumet
Janumet XR is a drug that combines sitagliptin and metformin.
View details →
miglitol
Glyset
Miglitol (Glyset) helps control blood sugar in adults with type 2 diabetes.
View details →
nateglinide
Starlix
Nateglinide (Starlix) helps control blood sugar in adults with type 2 diabetes.
View details →
phentermine
Adipex-P, Lomaira
Phentermine is a drug that can help you lose weight.
View details →
pioglitazone
Actos
Pioglitazone (Actos) is a medicine that helps control blood sugar levels in adults with type 2 diabetes.
View details →
pramlintide
Symlin
Symlin is a drug that helps control blood sugar in people with type 1 or type 2 diabetes who also use insulin.
View details →
repaglinide
Prandin
Repaglinide (Prandin) helps control blood sugar in adults with type 2 diabetes.
View details →
rosiglitazone
Avandia
View details →
saxagliptin
Onglyza
View details →
semaglutide
Ozempic, Wegovy, Rybelsus
Ozempic is a medicine that helps lower blood sugar in adults with type 2 diabetes.
View details →
sitagliptin
Januvia
View details →
tirzepatide
Mounjaro, Zepbound
Zepbound is a medicine that can help adults with obesity or overweight lose weight and keep it off.
View details →
Understanding the Diabetes Category
The Diabetes category currently lists 43 medications in this database, each drawn from FDA drug labels and grouped by therapeutic classification. Drugs for managing type 1 and type 2 diabetes, including insulin, metformin, and newer agents like GLP-1 agonists and SGLT2 inhibitors. Clinical guidelines usually treat these medications as a reference set when weighing treatment options, switching strategies, or comparing safety profiles.
Within this category you'll find examples such as metformin, insulin glargine, insulin lispro, alongside 40 other entries. Each drug page links to the same underlying FDA data, labeled uses, adverse events reported to FAERS, documented interactions, warnings, and, where available, NADAC acquisition pricing from CMS. Over-the-counter and prescription options can sit in the same category but follow different regulatory pathways: OTC products have simplified labeling aimed at self-care, while prescription drugs include detailed monographs meant for clinicians. That distinction matters when comparing dosing, monitoring requirements, and contraindications.
Browsing a category is a research starting point, not a treatment recommendation. Effectiveness, tolerability, and cost for any individual patient depend on the specific condition, comorbidities, other medications, genetics, and insurance coverage, none of which can be inferred from a category list alone. FAERS report counts, recall history, and shortage status all evolve as new data is reported to the FDA, so the relative standing of drugs in this class can shift month to month. This page is for educational purposes only and is not medical advice, a licensed clinician is the right source for personalized guidance.
Explore other categories
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.